London Cartilage Clinic
Explore expert articles on cartilage care, regenerative treatments, and practical recovery advice from our specialist team.
An untreated ACL tear permits 3–5 mm excess tibial movement during ordinary weight-bearing, progressively overloading cartilage that cannot repair itself; symptomatic osteoarthritis develops in approximately 35% of patients within ten years.
Knee replacement at forty-five carries a 35% lifetime revision risk versus 5% at seventy; osteotomy corrects load distribution, cartilage repair restores the surface, and load management reduces forces, together deferring replacement by a decade or two.
Grade III/IV knee osteoarthritis presents cartilage loss and synovial inflammation as separate problems in distinct anatomical compartments. ChondroFiller scaffolds the cartilage surface whilst Arthrosamid's permanent hydrogel cushions the synovial lining, neither product reaching the other's target and allowing both to be injected in a single appointment.
Persistent deep groin pain in women often stems from femoroacetabular impingement — abnormal hip bone pinching the labrum during flexion; early diagnosis prevents progressive joint deterioration.
ChondroFiller, an acellular collagen scaffold injected into the hip, recruits the patient's own progenitor cells to support cartilage repair. Candidacy includes both focal lesions and advanced OA, with mechanical joint stability — not age — as the primary gating factor.
MACI shows 92% pain satisfaction at ten years with a 9% reoperation rate; single-stage alternatives match it at two years with unproven long-term durability.
